AI healthcare companies · openevidence.com
OpenEvidence valuation, funding and revenue
OpenEvidence is a medical search and AI application for verified U.S. clinicians that answers clinical questions with references to medical literature at the point of care. It is free for verified clinicians and supported by advertising.
Figures checked September 2026. Each one links to its source.
Website visits
14M
Estimated, August 2026. +4% on the month before.
What is OpenEvidence's valuation?
OpenEvidence was valued at $15B in September 2026, according to press reports (axios.com). A private company's valuation is set when it raises money, so it can be well out of date between rounds.
How much funding has OpenEvidence raised?
OpenEvidence has raised $700M in total, as of January 2026 (techcrunch.com). The latest round was a $250M round in September 2026, according to press reports.
| Date | Round | Amount | Led by | Valuation | Source |
|---|---|---|---|---|---|
| September 2026 | Unnamed round | $250M | – | $15B | axios.com (reported) |
| January 2026 | Series D | $250M | Thrive Capital, DST Global | $12B | techcrunch.com |
| October 2025 | Unnamed round | $200M | GV (Google Ventures) | $6B | techcrunch.com (reported) |
| July 2025 | Series B | $210M | GV (Google Ventures), Kleiner Perkins | $3.5B | openevidence.com |
What is OpenEvidence's revenue?
- More than $100M revenue in January 2026, the company said (techcrunch.com).
ARR (annual recurring revenue) is the yearly value of current subscriptions; annualized revenue scales a recent month or quarter up to a year. Neither is audited revenue. See what ARR is.
OpenEvidence website traffic
Estimated monthly visits to openevidence.com across all channels, rounded. +21% over three months to August 2026.
- May 202611M
- June 202611M
- July 202613M
- August 202614M
OpenEvidence competitors
AI companies in the same category (AI healthcare companies) with a similar amount of website traffic. Similar size and category do not mean identical products; check what each one sells.
Ubie
ubiehealth.com · 4.1M visits a month
Luma Health
lumahealth.io · 1.9M visits a month
Heidi Health
heidihealth.com · 1.9M visits a month
Doctronic
doctronic.ai · 1.4M visits a month
Freed
getfreed.ai · 910K visits a month
About OpenEvidence
- OpenEvidence is a medical search and AI application for verified U.S. clinicians that answers clinical questions with references to medical literature at the point of care. It is free for verified clinicians and supported by advertising. openevidence.com
- Founded in 2022. techcrunch.com
- Founders: Daniel Nadler. openevidence.com
- The September 2026 round is reported by Axios citing Business Insider: $250 million at a $15 billion valuation from Andreessen Horowitz and undisclosed hospital systems. No company announcement was found; the round name and lead investors are not confirmed. axios.com
- The October 2025 round ($200 million at $6 billion, led by GV) was reported by TechCrunch citing The New York Times ahead of a company announcement. techcrunch.com
- The $100 million revenue figure has no stated time period (not stated as annualized or ARR). techcrunch.com
Get two growing AI companies and two rising searches every Monday.
Free. The paid database tracks every company's traffic, growth and modeled revenue week by week. Compare plans.
Sources
Checked on 29 September 2026. Traffic figures are third-party estimates, not company-reported numbers.
- https://www.openevidence.com/announcements/openevidence-the-fastest-growing-application-for-physicians-in-history-announces-dollar210-million-round-at-dollar35-billion-valuation
- https://techcrunch.com/2025/10/20/openevidence-the-chatgpt-for-doctors-raises-200m-at-6b-valuation/
- https://www.axios.com/pro/health-tech-deals/2026/09/25/openevidence-250m-raise-15b-valuation-a16z
- https://techcrunch.com/2026/01/21/openevidence-hits-12b-valuation-with-new-round-led-by-thrive-dst/